Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001464583-25-000003

CHIEF ACCOUNTING OFFICER gave up 85 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Megna Michael R · CHIEF ACCOUNTING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-04 Exercise or conversion : show line 1 in the form +175 38,186 D
2025-10-04 Shares withheld for taxes : show line 2 in the form −85 $38.49 $3,272 38,101 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-04 Exercise or conversion : show line 3 in the form Restricted Share Unit −175 0 D
Loading xslF345X05/form4-10082025_081015.xml…